£141.08

It has never been this cheap. We have no record of a lower price.

£141 today · cheaper than every other day in the last 3 months

Humana Cancer Diagnostics: Current and Future Trends (Contemporary Cancer Research)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 84 days · 84 data points (no recent data)

Historical
Generating forecast…
£141.08 £134.03 £136.85 £139.67 £142.49 £145.31 £148.13 12 August 2026 01 September 2026 22 September 2026 13 October 2026 03 November 2026
View at Amazon ↗

Price data checked 7 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 84 days • 1 price levels

Days at Price
84 days 0 21 42 63 84 £141 Days at Price

Price Analysis

Most common price: £141 (84 days, 100.0%)

Price range: £141 - £141

Price levels: 1 different prices over 84 days

Description

In the past, many tumor marker laboratory tests have not been sensitive enough for the very early detection of cancer. However, many of them have nonetheless proved useful in monitoring therapy, following the course of the tumor, and predicting prog- nosis. Today, cancer may be viewed as a genetic disease with various specific chromo- somal and nucleotide aberrations, such as mutations, deletions, gene amplification, gene rearrangements, and translocations occurring during the transformation of a nor- mal cell into a malignant cell. The considerable advances in technology during the past several years have greatly enhanced our ability to detect human cancers in the very early stages of tumor forma- tion. These technologies include: (1) nucleotide molecular assays (genomics); (2) proteomics (multiplex protein measurements); (3) DNA microarrays; and (4) bio- informatics. Many of these technologies are already helping in the integration and use of multiple biomarkers for tumors. Although the individual biomarkers may reveal only limited information, the use of multiple biomarkers can help markedly elevate the diagnostic capabilities for early detection of tumors.

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Release Date
09 December 2010
Listed Since
01 October 2010

Barcode

No barcode data available

Similar Products You Might Like

Tumor Biomarker Discovery: Methods and Protocols: 520 (Methods in Molecular Biology, 520)
87% match

Tumor Biomarker Discovery: Methods and Protocols: 520 (Methods in Molecular Biology, 520)

Humana

£82.35 12 Sep 2026
Cancer Gene Therapy (Contemporary Cancer Research)
86% match

Cancer Gene Therapy (Contemporary Cancer Research)

Humana

£166.07 24 Oct 2026
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
86% match

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Humana

£141.86 24 Oct 2026
Molecular Diagnosis of Cancer: Methods and Protocols: 97 (Methods in Molecular Medicine, 97)
86% match

Molecular Diagnosis of Cancer: Methods and Protocols: 97 (Methods in Molecular Medicine, 97)

Humana

£80.67 22 Oct 2026
New Advances on Disease Biomarkers and Molecular Targets in Biomedicine
84% match

New Advances on Disease Biomarkers and Molecular Targets in Biomedicine

Humana

£88.21 04 Nov 2026
Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)
84% match

Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£165.10 24 Oct 2026
Serological Cancer Markers: 11 (Contemporary Biomedicine, 11)
83% match

Serological Cancer Markers: 11 (Contemporary Biomedicine, 11)

Humana

£81.74 26 Oct 2026
Cancer Cytogenetics: Methods and Protocols: 730 (Methods in Molecular Biology, 730)
83% match

Cancer Cytogenetics: Methods and Protocols: 730 (Methods in Molecular Biology, 730)

Humana

£108.30 15 Oct 2026
Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)
83% match

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£144.51 23 Oct 2026
Cancer Cytogenetics: Methods and Protocols: 730 (Methods in Molecular Biology, 730)
83% match

Cancer Cytogenetics: Methods and Protocols: 730 (Methods in Molecular Biology, 730)

Humana

£80.67 25 Oct 2026
Cancer Biomarkers: Analytical Techniques for Discovery: 25 (Wiley Series on Mass Spectrometry)
82% match

Cancer Biomarkers: Analytical Techniques for Discovery: 25 (Wiley Series on Mass Spectrometry)

Wiley

£112.89 27 Oct 2026
Modern Molecular Biology:: Approaches for Unbiased Discovery in Cancer Research (Applied Bioinformatics and Biostatistics in Cancer Research)
82% match

Modern Molecular Biology:: Approaches for Unbiased Discovery in Cancer Research (Applied Bioinformatics and Biostatistics in Cancer Research)

Springer

£107.87 22 Oct 2026
Patient Surveillance After Cancer Treatment (Current Clinical Oncology)
82% match

Patient Surveillance After Cancer Treatment (Current Clinical Oncology)

Humana

£141.67 02 Nov 2026
Patient Surveillance After Cancer Treatment (Current Clinical Oncology)
82% match

Patient Surveillance After Cancer Treatment (Current Clinical Oncology)

Humana

£156.70 30 Oct 2026
Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)
82% match

Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)

Humana

£69.37 22 Oct 2026
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
82% match

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Humana

£148.21 22 Oct 2026
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)
82% match

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Humana

£76.42 23 Oct 2026
Advanced Protocols in Cancer Research: Translational Models for Antitumor and Anticancer Drug Discovery (Springer Protocols Handbooks)
81% match

Advanced Protocols in Cancer Research: Translational Models for Antitumor and Anticancer Drug Discovery (Springer Protocols Handbooks)

Humana

£110.81 16 Oct 2026
Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)
81% match

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Humana

£37.01 28 Oct 2026
Pancreatic Cancer: Pathogenesis, Diagnosis, and Treatment
81% match

Pancreatic Cancer: Pathogenesis, Diagnosis, and Treatment

Humana

£77.54 24 Oct 2026
Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)
81% match

Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)

Humana

£73.14 24 Oct 2026
Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs: Cell Signaling Pathways and microRNAs in Cancer Biology
81% match

Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs: Cell Signaling Pathways and microRNAs in Cancer Biology

Springer

£107.85 15 Oct 2026
Cancer Biomarkers in Body Fluids: Biomarkers in Circulation
81% match

Cancer Biomarkers in Body Fluids: Biomarkers in Circulation

Springer

£147.56 22 Oct 2026
Gene Therapy of Solid Cancers: Methods and Protocols: 1317 (Methods in Molecular Biology, 1317)
81% match

Gene Therapy of Solid Cancers: Methods and Protocols: 1317 (Methods in Molecular Biology, 1317)

Humana

£73.56 23 Oct 2026